What is Pure Diagnostic?
Pure Diagnostic operates as a CLIA-certified laboratory, providing a comprehensive suite of diagnostic services that include genetic testing, toxicology, and infectious disease screening. By positioning itself as a critical partner for pain management clinics, family practices, and addiction specialists, the company addresses the growing demand for precise medication compliance monitoring and rapid diagnostic turnaround. Their business model leverages web-based ordering systems and a focus on personalized clinical support to streamline the diagnostic workflow for healthcare providers. This operational efficiency is central to their value proposition, allowing clinicians to make informed, data-backed decisions in patient care environments where speed and accuracy are paramount.
How much funding has Pure Diagnostic raised?
Pure Diagnostic has raised a total of $169K across 1 funding round:
Debt
$169K
Debt (2021): $169K with participation from PPP
Key Investors in Pure Diagnostic
PPP
Public-Private Partnership
What's next for Pure Diagnostic?
With the infusion of this recent capital, Pure Diagnostic is well-positioned to accelerate its strategic expansion. The company is expected to focus on enhancing its laboratory automation and expanding its diagnostic menu to meet the evolving needs of the healthcare sector. By optimizing its supply chain and investing in advanced analytical technologies, the firm aims to further reduce sample turnaround times, thereby increasing its market share among high-volume clinical practices. As the diagnostic landscape shifts toward more personalized and rapid-response testing, Pure Diagnostic's focus on reliable, web-integrated services provides a robust foundation for sustained growth and long-term operational excellence in the diagnostic testing market.
See full Pure Diagnostic company page
